-+ 0.00%
-+ 0.00%
-+ 0.00%

Sunshine Biopharma wins Canadian approval for generic Xarelto drug rivaroxaban tablets

PUBT·06/01/2026 12:02:15
Listen to the news
Sunshine Biopharma wins Canadian approval for generic Xarelto drug rivaroxaban tablets
  • Sunshine Biopharma received Canadian approval for generic rivaroxaban tablets, a copy of Bayer’s Xarelto anticoagulant.
  • Product launch planned for October 2026 through its Canadian unit Nora Pharma’s distribution network.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunshine Biopharma Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202606010800ACCESSWRNAPR_____1172103) on June 01, 2026, and is solely responsible for the information contained therein.